| Year |
Citation |
Score |
| 2017 |
Biryukov J, Myers JC, McLaughlin-Drubin ME, Griffin HM, Milici J, Doorbar J, Meyers C. Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation. Viruses. 9. PMID 29257050 DOI: 10.3390/V9120385 |
0.686 |
|
| 2017 |
Soto DR, Barton C, Munger K, McLaughlin-Drubin ME. KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress. Plos Pathogens. 13: e1006661. PMID 28968467 DOI: 10.1371/Journal.Ppat.1006661 |
0.655 |
|
| 2017 |
Soto D, Song C, McLaughlin-Drubin ME. Epigenetic Alterations in Human Papillomavirus-Associated Cancers. Viruses. 9. PMID 28862667 DOI: 10.3390/V9090248 |
0.565 |
|
| 2015 |
McLaughlin-Drubin ME. Human papillomaviruses and non-melanoma skin cancer. Seminars in Oncology. 42: 284-90. PMID 25843732 DOI: 10.1053/J.Seminoncol.2014.12.032 |
0.72 |
|
| 2013 |
Munger K, Gwin TK, McLaughlin-Drubin ME. p16 in HPV-associated cancers. Oncotarget. 4: 1864-5. PMID 24192550 DOI: 10.18632/Oncotarget.1523 |
0.668 |
|
| 2013 |
McLaughlin-Drubin ME, Park D, Munger K. Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proceedings of the National Academy of Sciences of the United States of America. 110: 16175-80. PMID 24046371 DOI: 10.1073/Pnas.1310432110 |
0.527 |
|
| 2013 |
McLaughlin-Drubin ME, Munger K. Biochemical and functional interactions of human papillomavirus proteins with polycomb group proteins. Viruses. 5: 1231-49. PMID 23673719 DOI: 10.3390/V5051231 |
0.576 |
|
| 2012 |
Herfs M, Yamamoto Y, Laury A, Wang X, Nucci MR, McLaughlin-Drubin ME, Münger K, Feldman S, McKeon FD, Xian W, Crum CP. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 10516-21. PMID 22689991 DOI: 10.1073/Pnas.1202684109 |
0.731 |
|
| 2012 |
McLaughlin-Drubin ME, Meyers J, Munger K. Cancer associated human papillomaviruses. Current Opinion in Virology. 2: 459-66. PMID 22658985 DOI: 10.1016/J.Coviro.2012.05.004 |
0.754 |
|
| 2012 |
Xylas J, McLaughlin-Drubin M, Münger K, Georgakoudi I. Elucidating metabolic, subcellular, and tissue-level changes induced by HPV-related oncoproteins Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2012.Bsu3A.33 |
0.661 |
|
| 2011 |
McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proceedings of the National Academy of Sciences of the United States of America. 108: 2130-5. PMID 21245294 DOI: 10.1073/Pnas.1009933108 |
0.744 |
|
| 2009 |
McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Research. 143: 195-208. PMID 19540281 DOI: 10.1016/J.Virusres.2009.06.008 |
0.726 |
|
| 2009 |
McLaughlin-Drubin ME, Münger K. The human papillomavirus E7 oncoprotein. Virology. 384: 335-44. PMID 19007963 DOI: 10.1016/J.Virol.2008.10.006 |
0.725 |
|
| 2008 |
Nguyen CL, McLaughlin-Drubin ME, Münger K. Delocalization of the microtubule motor Dynein from mitotic spindles by the human papillomavirus E7 oncoprotein is not sufficient for induction of multipolar mitoses. Cancer Research. 68: 8715-22. PMID 18974113 DOI: 10.1158/0008-5472.Can-08-1303 |
0.673 |
|
| 2008 |
McLaughlin-Drubin M, Münger K. The human papillomavirus type 8 E2 gene encodes a transforming activity sufficient for skin tumor formation in transgenic mice. The Journal of Investigative Dermatology. 128: 2142-4. PMID 18695686 DOI: 10.1038/Jid.2008.217 |
0.593 |
|
| 2008 |
McLaughlin-Drubin ME, Huh KW, Münger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. Journal of Virology. 82: 8695-705. PMID 18579589 DOI: 10.1128/Jvi.00579-08 |
0.611 |
|
| 2008 |
McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochimica Et Biophysica Acta. 1782: 127-50. PMID 18201576 DOI: 10.1016/J.Bbadis.2007.12.005 |
0.327 |
|
| 2006 |
Drubin DA, McLaughlin-Drubin ME, Clawson GA, Meyers C. A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 1142-8. PMID 16564747 DOI: 10.1016/J.Ymthe.2006.02.005 |
0.791 |
|
| 2005 |
McLaughlin-Drubin ME, Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods in Molecular Medicine. 119: 171-86. PMID 16350404 DOI: 10.1385/1-59259-982-6:171 |
0.801 |
|
| 2005 |
McLaughlin-Drubin ME, Bromberg-White JL, Meyers C. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology. 338: 61-8. PMID 15921717 DOI: 10.1016/J.Virol.2005.04.036 |
0.759 |
|
| 2005 |
Sen E, McLaughlin-Drubin M, Meyers C. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication. Anticancer Research. 25: 1091-100. PMID 15868951 |
0.747 |
|
| 2005 |
Alam S, Bromberg-White J, McLaughlin-Drubin M, Sen E, Bodily JM, Meyers C. Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium. Anticancer Research. 25: 765-77. PMID 15868908 |
0.69 |
|
| 2004 |
McLaughlin-Drubin ME, Christensen ND, Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology. 322: 213-9. PMID 15110519 DOI: 10.1016/J.Virol.2004.02.011 |
0.816 |
|
| 2004 |
McLaughlin-Drubin ME, Meyers C. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology. 321: 173-80. PMID 15051378 DOI: 10.1016/J.Virol.2003.12.019 |
0.802 |
|
| 2003 |
McLaughlin-Drubin ME, Wilson S, Mullikin B, Suzich J, Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology. 312: 1-7. PMID 12890615 DOI: 10.1016/S0042-6822(03)00312-X |
0.817 |
|
| Show low-probability matches. |